A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• HIV-1 infection affects the central nervous system early, but neurological impairment manifests later.
• Monocyte infiltration into the brain is linked to HIV-1 encephalitis and dementia.
• Understanding monocyte transmigration across the blood-brain barrier (BBB) is crucial for HIV neuropathogenesis.

Purpose of the Study:

• To investigate the mechanisms of monocyte penetration across the BBB in the context of HIV-1 infection.
• To differentiate the roles of viral factors versus immune activation in monocyte migration.

Main Methods:

• Construction of an artificial BBB model using brain microvascular endothelial cells (BMVEC) and astrocytes.
• Co-culture of HIV-infected or uninfected monocytes (with or without immune stimulation) with the BBB model.
• Analysis of monocyte migration, cellular changes, and cytokine production.

Main Results:

• Immune-stimulated monocytes (LPS-treated) significantly increased transmigration (up to 20-fold) by disrupting BMVEC tight junctions.
• Activated monocytes exhibited enhanced cellular activity, including filopodia and vesicular transport.
• HIV-1 infection alone did not enhance monocyte migration across the BBB.
• Activated monocytes released high levels of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-10).

Conclusions:

• Immune activation, rather than direct viral infection, is a primary driver of monocyte migration across the BBB during HIV encephalitis.
• This monocyte infiltration contributes to neuropathogenesis and clinical dementia in HIV-1 infection.